aucubin has been researched along with Age-Related Osteoporosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, M; Li, Y; Liu, X; Song, M; Wang, D; Yang, A; Zhang, Y | 1 |
| Hu, M; Li, Y; Liu, X; Lu, W; Wang, D; Zhang, X; Zhang, Y | 1 |
2 other study(ies) available for aucubin and Age-Related Osteoporosis
| Article | Year |
|---|---|
Aucubin slows the development of osteoporosis by inhibiting osteoclast differentiation via the nuclear factor erythroid 2-related factor 2-mediated antioxidation pathway.
Topics: Animals; Antioxidants; Cell Differentiation; Dexamethasone; Disease Models, Animal; Dose-Response Relationship, Drug; Iridoid Glucosides; Male; Mice; Mice, Inbred C57BL; NF-E2 Transcription Factor, p45 Subunit; Osteoclasts; Osteoporosis; RAW 264.7 Cells | 2021 |
Aucubin exerts anti-osteoporotic effects by promoting osteoblast differentiation.
Topics: Animals; Apoptosis; Bone and Bones; Cell Differentiation; Cell Line; Cell Proliferation; Collagen Type I; Cytokines; Dexamethasone; GA-Binding Protein Transcription Factor; Glucocorticoids; Humans; Hydrogen Peroxide; Iridoid Glucosides; Mice; Osteoblasts; Osteocalcin; Osteopontin; Osteoporosis; Oxidants; Oxidative Stress; Proto-Oncogene Proteins c-akt; Signal Transduction; Smad Proteins; Sp7 Transcription Factor | 2020 |